Actuate Therapeutics Inc (ACTU)
NASDAQ: ACTU
· Real-Time Price · USD
8.12
-0.13 (-1.58%)
At close: Aug 19, 2025, 1:52 PM
Actuate Therapeutics Inc Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -23.75M | -25.16M | -26.22M | -27.3M | -27.45M | -24.97M | -17.36M | -10.88M | -5.3M |
Interest Income | 261.13K | 222.29K | 163.87K | 209.06K | 315.81K | 301.02K | 241.33K | 115.39K | n/a |
Pretax Income | -25.31M | -27.29M | -28.45M | -28.82M | -27.77M | -24.74M | -17.13M | -10.79M | -5.27M |
Net Income | -25.31M | -27.29M | -28.45M | -28.82M | -27.77M | -24.74M | -17.13M | -10.79M | -5.27M |
Selling & General & Admin | 8.72M | 6.48M | 4.58M | 3.66M | 3.4M | 3.27M | 2.3M | 1.58M | 774.8K |
Research & Development | 15.04M | 18.68M | 21.64M | 23.64M | 24.05M | 21.71M | 15.06M | 9.3M | 4.52M |
Other Expenses | n/a | n/a | n/a | n/a | -0.00 | -0.00 | -0.00 | -0.00 | n/a |
Operating Expenses | 23.75M | 25.16M | 26.22M | 27.3M | 27.45M | 24.97M | 17.36M | 10.88M | 5.3M |
Interest Expense | 18.7K | 18.72K | 18.7K | 20.28K | 15.2K | 10.13K | 5.06K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.39M | 25.16M | 26.22M | 27.3M | 27.45M | 24.97M | 17.36M | 10.88M | 5.3M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 19.5M | 10.77M | 10.77M | 19.53M | 15.49M | 15.26M | 15.49M | 14.22M | 13.39M |
Shares Outstanding (Diluted) | 19.5M | 10.77M | 10.77M | 19.53M | 15.49M | 15.26M | 15.49M | 14.22M | 13.4M |
EPS (Basic) | -1.81 | -2.03 | -1.93 | -1.79 | -1.84 | -1.69 | -1.19 | -0.78 | -0.39 |
EPS (Diluted) | -1.81 | -2.03 | -1.93 | -1.79 | -1.84 | -1.69 | -1.19 | -0.78 | -0.39 |
EBITDA | -25.34M | -27.27M | -28.43M | -28.8M | -22.23M | -13.94M | -6.33M | n/a | n/a |
EBIT | -18.98M | -27.27M | -28.43M | -28.8M | -27.82M | -24.82M | -17.22M | -10.88M | -5.3M |
Depreciation & Amortization | -1.59M | -2.11M | -2.22M | -1.5M | 5.22M | 11.03M | 11.03M | 10.88M | 5.3M |